Helen Ross‐Adams
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 6
- Breast Cancer Treatment Studies 2
- Clinical Biochemistry top 10%
-
- Pancreatic and Hepatic Oncology Research 4
- Cancer Cells and Metastasis 3
-
- Prostate Cancer Treatment and Research 5
- Prostate Cancer Diagnosis and Treatment 2
-
- Molecular Biology Techniques and Applications 2
- Epigenetics and DNA Methylation 2
- Co-authors
- Claude ChelalaHemant M. KocherLavanya SivapalanMary Joan MacLeodGraeme J. ThornIan G. MillsDavid E. NealEmanuela Gadaleta
- Partner nations
- United KingdomGermanyAustralia
In The Last Decade
Helen Ross‐Adams
15 papers receiving 493 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 174
- Clinical Biochemistry 41
- Genetics 109
- Oncology 106
- Pulmonary and Respiratory Medicine 118
Countries citing papers authored by Helen Ross‐Adams
This map shows the geographic impact of Helen Ross‐Adams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Ross‐Adams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Ross‐Adams more than expected).
Fields of papers citing papers by Helen Ross‐Adams
This network shows the impact of papers produced by Helen Ross‐Adams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Ross‐Adams. The network helps show where Helen Ross‐Adams may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Helen Ross‐Adams, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2022 | 42 | |
| 3 | 2022 | 14 | |
| 4 | 2022 | 14 | |
| 5 | 2021 | 7 | |
| 6 | 2020 | 41 | |
| 7 | 2020 | 8 | |
| 8 | 2017 | 21 | |
| 9 | 2017 | 12 | |
| 10 | 2016 | 81 | |
| 11 | 2015 | 10 | |
| 12 | 2014 | 47 | |
| 13 | 2013 | 4 | |
| 14 | The RS10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine | 2011 | 3 |
| 15 | 2009 | 149 | |
| 16 | Sequence Variants on Chromosome 9p21 Confer Risk of Large Vessel Stroke. | 2009 | 0 |
| 17 | 2006 | 47 |
About Helen Ross‐Adams
Helen Ross‐Adams is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 17 papers that have together received 500 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (6 papers), Prostate Cancer Treatment and Research (5 papers), Pancreatic and Hepatic Oncology Research (4 papers), Cancer Cells and Metastasis (3 papers), Breast Cancer Treatment Studies (2 papers), Prostate Cancer Diagnosis and Treatment (2 papers), Molecular Biology Techniques and Applications (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (174 citations), Clinical Biochemistry (41 citations) and Genetics (109 citations). Helen Ross‐Adams has collaborated with scholars based in United Kingdom, Germany and Australia. Frequent co-authors include Claude Chelala, Hemant M. Kocher, Lavanya Sivapalan, Mary Joan MacLeod, Graeme J. Thorn, Ian G. Mills, David E. Neal, Emanuela Gadaleta, J. Louise Jones and Steve Bevan. Their work appears in journals such as Nature Genetics, Cancer Research and Annals of Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.